In Vivo Pharmacodynamic Activity of Gatifloxacin (GATI), Levofloxacin (LEVO), and Moxifloxacin (MOXI) against Staphylococcus aureus with Reduced Susceptibility to Fluoroquinolones (FQs)
In Vivo Pharmacodynamic Activity of Gatifloxacin (GATI), Levofloxacin (LEVO), and Moxifloxacin (MOXI) against Staphylococcus aureus with Reduced Susceptibility to Fluoroquinolones (FQs), Lead author: Craig WA, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC
